1. Beyer C, Distler O, Distler JH. Innovative antifibrotic therapies in systemic sclerosis. Curr Opin Rheumatol. 2012;24(3):274–80.
2. Denton CP, Black CM. Scleroderma (systemic sclerosis). In: Wolff K, Goldsmith LA, Katz SI, Gilchrist BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York, NY: McGraw-Hill Medical Publishing Division; 2008. p. 1553–62.
3. Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):432–7.
4. Fox P, Chung L, Chang J. Management of the hand in systemic sclerosis. J Hand Surg [Am]. 2013;38(5):1012–6.
5. Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, Hinchcliff ME, Steen V, Khanna D, Kayser C, Domsic RT. Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol. 2013;31(2 Suppl 76):166–71.